lung_transplant_2

Primary graft dysfunction (seen above) is an often fatal complication that follows a lung transplant. The incidence of PGD is about 10 to 20 percent, according to data from the United Network for Organ Sharing. Mortality from PGD can be as high as 40 percent a month after transplant. Efforts to identify which recipients will develop PGD have so far been unsuccessful, but the discovery of an inflammation biomarker may help. (Courtesy: Emory)

EMORY (US)—Researchers have identified a marker of inflammation that may help predict an often fatal complication following a lung transplant.

“Despite major advances in surgical techniques and clinical management, serious lung transplant complications are common and often untreatable,” says Andrea Pelaez, a pulmonary medicine specialist at Emory University.

“Primary graft dysfunction (PGD) is a severe lung injury appearing just a few days after transplantation. Unfortunately, predicting which lung transplant recipients go on to develop PGD has been so far unsuccessful. Therefore, our research has been directed towards identifying predictive markers in the donor lungs prior to transplantation.”

Because of the lack of suitable donors, hundreds of people die annually waiting for a lung transplant. A biomarker approach to screening donor tissue could actually expand the number of suitable organs by reclassifying some previously unusable organs as suitable.

The results are published in the American Journal of Transplantation.

The incidence of PGD is about 10 to 20 percent, according to data from the United Network for Organ Sharing. Mortality from PGD can be as high as 40 percent a month after transplant.

Known risk factors for the development of PGD include lung donor age over 50, a history of smoking, and injury to the lungs.

Levels of a protein called “receptor for advanced glycation end products” (RAGE) may predict which lungs develop early complications after transplantation, the authors found.

RAGE is present in lung cells under normal conditions; however, it is released into the fluid surrounding the cells and into the blood following injury or inflammation.

The authors measured RAGE by obtaining a saline rinse from donor lungs prior to procurement and found that the odds of developing severe PGD were higher as the levels of detected RAGE increased.

A more extensive study involving a larger cohort size is needed to validate the results, and to determine the precise levels of RAGE that predict the development of PGD after lung transplantation, the researchers say.

The research was supported by a grant from the National Institute for Alcohol Abuse and Alcoholism to the Emory Alcohol and Lung Biology Center.

Emory University health news: http://emoryhealthsciences.org